NCT07387926 2026-02-04Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)NovartisPhase 1/2 Not yet recruiting50 enrolled
NCT07365995 2026-01-26A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerBioNTech SEPhase 3 Not yet recruiting736 enrolled